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Abstract
Background: Parkinson’s Disease (PD) is a neurodegenerative disorder affecting the
motor system. It is a chronic progressive disorder that leads to long standing disability.
Objective: To study the presentations and PINK1 gene in young Sudanese patients
with PD.
Methods: A prospective study was conducted among 31 PD patients at the National
center for Neurological Science (NCNS) at Khartoum state. A structured questionnaire
was used for data collection. This consisted of personal data, clinical presentations,
and investigations. RT-PCR technique was done using G-spinTM kit. PINK1 gene was
detected in most of the samples and was strongly positive. Data was analyzed using
SPSS version 21.
Results: The majority of them, 19 (61%), were located in age group 41–50 years; the
mean age of onset was 33.4 ± 12 yr; Our of the total number of subjects, 19 (61%)
were male and 12 (39%) were female with a ratio 1.6:1 (M:F); 20 (64.5%) were married
and 8 (40%) were endogamous married; 5 (62.5%) were second degree and 3 (37.5%)
were third degree, 17 (85%) had children and 2 (10%) had children with PD; 22 (71%)
had duration more than 12 months and 12 (39%) were more than 40 years old; 29
(93.5%) had tremor, 27 (87.1%) had rigidity, 23 (74.2%) had bradykinesia, and 14 (45%)
had positive family history of PD. PINK1 gene expression was detected in 28 (90.3%)
patients. No significant associations were found between PINK1 expression and age,
gender, age at onset, and family history (P > 0.05).
Conclusion: This study concludes that early onset PD was common among males than
females. The most affected age group was found to be 41–50 years and the mean age
of onset was 33.4 yr. Also, the patterns of the clinical features were generally similar to
literature. PINK1 expression was predominant with no significant associations between
PINK1 expression with age, gender, age at onset, and family history.
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1. Introduction
Parkinson’s disease (PD) is a progressive neurodegenerative illness. It was first
described by James Parkinson in his classic 1817 monograph, “An Essay on the Shaking
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Palsy” [1], PD, also known as paralysis agitans, is a progressive neurodegenerative
disease that affects between 100 and 200 per 100,000 people over 40, and over 1
million people in North America alone [2, 3]. It is uncommon in people younger than
40, and the incidence of the disease increases rapidly over 60 years, with a mean age
of 70.5 yr at the time of diagnosis [4].
While PD has traditionally been considered a motor system disorder, it is now rec-
ognized to be a complex condition with diverse clinical features that include neuropsy-
chiatric and other non-motor manifestations in addition to its motor symptomatology
(5).
Young-onset Parkinson’s disease (YOPD) is a subtype of PD, occurring at a younger
age, with specific symptoms, genetic correlation, and treatment strategies. YOPD is
defined as a diagnosis of PD between the ages of 21 and 40 [6]. A positive PD diagnosis
under the age of 21 is referred to as “juvenile Parkinson’s” ( JP). Between 3 and 6% of
all PD cases are reported to be YOPD [7]. Although most clinical features of JP and
YOPD are the same, increased occurrence of dystonia and PD are found in patients
with JP [8]. The overall age and gender adjusted incidence of PD is 13.4 per 100,000,
whereas the incidences for people between the ages of 30 and 39, 40 and 49, and 50
and 59 are 0.5, 2.5, and 9.8 per 100,000, respectively [4]. Approximately 20% of YOPD
patients have at least one first- or second-degree relative with PD either in the same or
antecedent generation [4].
The cardinal features of PD are tremor, bradykinesia, and rigidity. A fourth feature,
postural instability, is commonly mentioned, although it does not generally occur until
much later in the course of the disease and is thus not included in any published
diagnostic criteria for PD [8].
Women and men are affected equally. Age at onset is highly variable, even in
individuals with the same pathogenic variant [9]; onset is usually in the third or fourth
decade [10]. In the study by Marongiu et al. (2008), the average age at onset in those
with two PINK1 pathogenic variants was 41 yr [11].
Bradykinesia and tremor are the most common presenting signs. In some individuals,
the symptoms at onset are symmetric. Dystonia and hyperreflexia may also be present
[10].
In addition to Parkinsonism, individuals with the PINK1 type of YOPD may be prone
to psychiatric involvement. Abnormal behavior and/or psychiatric manifestations (in
particular, depression and anxiety) occur in about 30 and 15% of affected individuals,
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respectively. Other features include hallucinations and dementia [12]. Non-motor symp-
toms are also frequent, and overall, the clinical signs at examination are also variable
[12].
On average, the response to levodopa is better than in other forms of Parkinson
disease [13]; however, the incidence of levodopa-induced dyskinesia may be greater
in individuals with PINK1-associated YOPD than in those with Parkinsonism of different
etiologies [14].
1.1. Problem statement
There are several genes that have been implicated in PD. Some rare mutations are
implicated in the onset of PD in a young age, usually before the age of 30; these
genes are PARK2, PARK6, and PARK7. Their abnormal gene products appear to affect
the function of the energy factory of the cell-the mitochondrion. Well understanding of
clinical presentation and causes of PD will lead to early diagnosis and give new ideas
about new modality of treatment.
1.2. Objective
To study PINK1 gene in early onset PD and its clinical presentations in Sudanese patients
at the National Center for Neurological Science (NCNS).
2. Methods
This was a prospective study conducted at the NCNS between December 2016 and
December 2018. Sudanese patients aged< 50 yr and diagnosedwith PDwere included.
Patients developing PD at age > 50 yr, patients with idiopathic PD, non-Sudanese
patients, and those who were unable or refused to answer the questionnaires were
excluded from the study. The sample size was 31 patients and data were collected
through a questionnaire.
2.1. Study variables
Patient’s age, gender, cause of disease, severity of symptoms, duration of the disease,
and motor abnormalities.
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2.2. Techniques
2.2.1. Blood collection
5ml of venous bloodwas collected in sterile containers and put in vaccination containers
and transported to laboratory for performance of genetic analysis.
2.2.2. Genetic analysis (PINK1)
DNA extraction: The extraction of DNA was carried out by using G-spinTM total DNA
extraction kit. Briefly, 20 μl of Proteinase K and 5 μl of RNase Solution were added
to 200 μl of the whole blood sample. Then, 200 μl of Buffer BL was added, mixed
thoroughly, incubated at 56°C for 10 min and centrifuged; 200 μl of absolute ethanol
was added to the mixture and mixed gently by pipette (5–6 times) and then centrifuged;
700 μl of Buffer WA was added and centrifuged (repeated twice). And then 100 μl of
Buffer CE was added for elution.
Real-time PCR process: Extracted DNA samples were then amplified by adding 2 μl
of DNA, 1 ml of forward primer, 1 ml of reverse primer, and 20 ml of water. Then, the
mixture was put in tubes placed in thermal cycler and amplification was performed. The
collected data were organized into a master sheet and then entered in the computer
using the Statistical Package for Social Sciences (SPSS) version 21. The results obtained
were presented in tables and figures. Chi-square test was used as significance test and
the level of significance was considered as P-value < 0.05.
2.3. Ethical consideration
Consent was taken from all participants and from the National Centre for Neurological
Science. Participation to the study was completely voluntary and confidentiality was
considered.
3. Results
Of the total of 31 patients, the majority of them were located in age group 41–50 yr, 19
(61%) of the subjects were male and 12 (39%) were female with a ratio 1.6:1 (M: F),
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22 (71%) had duration more than 12 months and 12 (39%) had age more than 40 yr,
followed by 11 (35%) in age group 20–40 yr and 8 (26%) less than 20 yr. Mean 33.6 ±
12.9 yr (Figures 1–3).
Figure 1: Age distribution among PINK1 early onset PD patients (n = 31).
Figure 2: Gender distribution among study group (n = 31).
PINK1 gene expression: 28 (90.3%) patients showed positive result and 3 (9.7%) showed
negative results (Figure 4).
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Figure 3: Gender distribution among study group (n = 31)The age of onset of PINK1 type early onset PD (n
= 31).
Figure 4: PINK1 gene expression distribution among the study group.
The association between PINK1 gene and age at onset: 100% of the patients in age
group less than 20, 81.8% in age group 20–40 yr, and 91.7% of the patients in age group
40–50 ys expressed PINK1 gene. But the difference was statistically insignificant (P =
0.408; Figure 5).
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Figure 5: PINK1 gene expression according to the age at onset.
Symptoms: 29 (93.5%) patients had tremor, 27 (87.1%) had rigidity, 23 (74.2%) had
bradykinesia, and 24 (77.4%) had tremor as initial symptoms.
27 (87.1%) patients had hand tremor, it was bilateral in 24 (85.7%) and symmetrical in
6 (25%), 12 (54.5%) had both types of rigidity (cogwheel and lead pipe), 30 (97%) had
monotonous speech (Tables 1 and 2); 20 patients (64.5%) were married, 8 (40%) were
endogamous married and 5 (62.5%) were second-degree and 3 (37.5%) were third-
degree relative; 17 (85%) patients had children, 2 (10%) had children with PD Table(3).






Family History: All of the patients have positive family history (100%) of PD and had 1–3
members of family with PD: 8 (57.1%) of them were first-degree members; 28.6% were
first- and second-degrees members, and 14.4% were third degree (Table 4).
Family members’ symptoms: 14 (100%) had rigidity, 13 (92.2%) had tremor, and 4 (28.6%)
had bradykinesia.
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Table 2: The signs of PINK1 early onset PD among the patients.
Signs N %
Tremor site
• Hand 27 87.1
• Head 1 3.2
Bilateral hand tremor 24 85.7
• Symmetrical 6 25
• Non-symmetrical 18 75
Rigidity type (n = 22)
• Cog-wheel 9 40.9
• Lead pipe 1 4.5
• Both 12 54.5
Table 3: Distribution of marital status, endogamous marriage and degree of relativity in endogamous
marriage among the study group.
N %
Marital status (n = 31)
• Married 20 64.5
• Unmarried 11 35.5
Endogamous marriage (n = 20)
• Yes 8 40
• No 12 60
Degree of relativity in endogamous marriage (n = 8)
• Second degree 5 62.5
• Third degree 3 37.5
Initial symptoms: 12 (85.7%) of them developed tremor and 2 (14.3%) developed rigidity.
Age and gender of the familymembers: 9 (64.3%) were in age group 20–35 yr, followed
by 21.4% that were in age group 36–50 yr and 14.3% > 50 years; 7 (50%) were males.
Brain imaging: 20 (64%) patients underwent CT brain, which was normal, 11 (36%)
underwent MRI brain, which was also normal.
Types of treatment: 23 (74%) patient used combined akisol and levocare, 5 (16%) used
Akisol, and 3 (10%) used levocare alone.
Association between PINK1 gene expression age: all of the patients (100%) in age group
–40 yr expressed PINK1 gene, followed by 89.5% in the age group 41–50 yr, and 88.9%
in age group 20–30 yr, the difference was statistically insignificant (P = 0.836). Gender:
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Table 4: Characteristics of family members of PINK1 early onset PD.
N %
Affected members (n = 14)
• 1–3 members 14 100
Degree of relativity (n = 14)
• First degree 8 57.1
• Third degree 2 14.4
• First and second degrees 4 28.6
Age (n = 14)
• 20–35 9 64.3
• 36–50 3 21.4
• > 50 2 14.3
Gender (n = 14)
• Male 7 50.0
• Female 4 28.6
• Both 3 21.4
Family blood genetic screening (n = 14)
No 14 100
91.7% of the female patients and 89.5% male expressed PINK1 gene, the difference was
statistically insignificant (P = 0.672).
Expression of PINK1 gene according to the family history: 92.9% of those with positive
family history and 88.2% with negative family history group expressed PINK1 gene. The
difference was statistically insignificant (P = 0.575). Also, all the patients had third-degree
member- and first- and second-degree member-expressed PINK1 gene, 85.7% of the
patients had first-degree relative-expressed PINK1 gene. The difference was statistically
insignificant (P = 0.629) (Tables 5 and 6).
4. Discussion
This study included 31 PD patients, among them males (61%) were affected more than
females (39%) with male to female ratio of 1.6:1; this is similar to other study conducted
by Khalda et al. in Sudan who found that male:female in PD was 1.5:1 [14].
The peak incidence of PD was found to be in the age group 41–50 yr (61%), mean
age was 33.4 yr, which was similar to the literature and Witjas et al. [4, 15].
Also, our study showed that most patients had tremor (93.5%), rigidity (87.1%), and
bradykinesia (74.2%); 77.4% had tremor as initial symptoms, this similar to the findings
of Khalda et al. [14] and goes well with what was mentioned in the literature [15].
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Table 5: Shows the association between PINK1 gene expression and demographic data of the study group.
PINK1 gene expression P-value
Yes (%) No (%)
Age 0.836
• 20–30 8 (88.9) 1 (11.1)
• 31–40 3 (100) 0 (0)
• 41–50 17 (89.5) 2 (10.5)
Gender 0.672
• Male 17 (89.5) 2 (10.5)
• Female 11 (91.7) 1 (8.3)
Marital status 0.719
• Married 18 (90) 2 (10)
• Unmarried 10 (90.9) 1 (9.1)
Chi-square test was used.
Table 6: Shows the association between PINK1 gene with affected family members.
PINK1 gene expression P-value
Yes (%) No (%)
Positive family history 0.575
• Yes 13 (92.9) 1 (7.1)
• No 15 (88.2) 2 (11.8)
Degree of relativity (n = 14)
• First degree 6 (85.7) 1 (14.3) 0.629
• Third degree 2 (100) 0 (0)
• First and second degrees 4 (100) 0 (0)
Regarding the PD signs, the majority of the subjects (87.1%) had hand tremor, it was
bilateral in 85.7% and symmetrical in 25%; 54.5% had both types of rigidity (cogwheel
and lead pipe) and this was in favor with what was mentioned in the literature [15].
The current study revealed that 45% of the patients had positive family history to
PD, this result was similar to Bentio et al.’s in Denmark [16], and differ from the study of
Khalda et al. [14] who found that small percentage of the PD patients (11.7%) had positive
family history.
Regarding PINK1 gene expression, this study presented that 90.3% of the patients
showed positive result. This is similar to those reported by Koziorowski et al who found
that mutations were identified only in the PARK2 and PINK1 genes with the frequency of
84.7% and 82.7% of subjects, respectively, and they conclude that the frequency of the
PARK2 and PINK1 mutations among Polish EO–PD patients seems to be high [17]. Also,
mutations in PINK1 were initially identified in early onset, autosomal recessive kindreds.
Point mutations, frame shift mutations, and truncating mutations have been reported
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throughout the gene. In addition, no significant associations were found between PINK1
expression and age, gender, age at onset, and family history (P > 0.05). These findings
go in line with what was mentioned in literature [18].
5. Conclusion
This study concludes that PINK1 gene seems predominant in Sudanese patients. It was
common among males than females. The most affected age group was found to be in
the third and fourth decades. The patterns of the clinical features were generally similar
to the literature. PINK1 expression was predominant with no significant associations
between PINK1 expression and age, gender, age at onset, and family history. PINK1
gene testing is recommended in all EOPD Sudanese patients.
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